IP Library Granted Patent US 7,534,836
Granted Patent B2
US 7,534,836 · App. 11/173,698 · Granted May 19, 2009

Biomedical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,836
App. No.
11/173,698
Granted
May 19, 2009
Kind
B2
Abstract

Biomedical devices are provided herein which are formed from a polymerization product of a monomeric mixture comprising one or more monomers comprising one or more trifluorovinyl groups, e.g., a perfluorocyclobutane containing polymer.

Claims (20)

1. An ophthalmic lens formed from a polymerization product of a monomeric mixture comprising one or more monomers having at least two dimerizable perfluorovinyl groups.

2. The ophthalmic lens of claim 1 , wherein the monomeric mixture comprises one or more monomers having at least two dimerizable perfluorovinyl ether groups.

3. The ophthalmic lens of claim 1 , wherein the monomeric mixture comprises one or more monomers having at least two dimerizable perfluorovinyl aromatic ether groups.

4. The ophthalmic lens of claim 1 , wherein the monomeric mixture comprises one or more monomers having at least two dimerizable perfluorovinyl groups of the general formula

F 2 C═CF—X—R 5 —(X—CF═CF 2 ) m

wherein R 5 represents one or more inertly substituted groups; X is independently a group which links the R 5 group and the trifluorovinyl group and m is an integer of 1 to about 1000.

5. The ophthalmic lens of claim 4 , wherein R 5 comprises a substituted or unsubstituted cyclic or polycyclic containing group or a substituted or unsubstituted cyclic or polycyclic siloxane containing group, X is independently a bond, an oxygen atom, a sulfur atom, a carboxylic or thiocarboxylic ester group, an amide group, a sulfone, a sulfoxide, a carbonate, a carbamate, a perfluoroalkylene, a perfluoroalkylene ether, an alkylene, an acetylene, a phosphine, a carbonyl or thiocarbonyl group; seleno; telluro; nitrido; a silanediyl group, a trisilanediyl group, a tetrasilanetetrayl group, a siloxanediyl group, a disiloxanediyl group, a trisiloxyldiyl group, a trisilazanyl group, a silythio group, or a boranediyl group and m is from 1 to about 10.

6. The ophthalmic lens of claim 4 , wherein each X is O, R 5 selected from the group consisting of

and wherein each O atom may independently be bonded to the aromatic group either ortho, meta and/or para with respect one another and m is 1 to about 5.

7. The ophthalmic lens of claim 1 , wherein the monomer mixture comprises one or monomers of the general formula

F 2 C═CF—X—R 6 —(X—CF═CF 2 ) m

wherein R 6 is one or more substituted or unsubstituted C 3 -C 25 cycloalkyl groups optionally containing one or more heteroatoms; each X is independently a group which links the R 6 group and the trifluorovinyl group; and m is an integer of 1 to about 1000.

8. The ophthalmic lens of claim 7 , wherein each X is O, R 6 is selected from the group consisting of

and m is 1 to about 10.

9. The ophthalmic lens of claim 4 , wherein the polymerization product is a thermal polymerization product.

10. The ophthalmic lens of claim 1 , wherein the ophthalmic lens is a contact lens.

11. The ophthalmic lens of claim 10 , wherein the contact lens is a rigid gas permeable lens.

12. An ophthalmic lens formed from a polymerization product of a monomeric mixture comprising one or more polysiloxane containing monomers having at least two dimerizable perfluorovinyl groups.

13. The ophthalmic lens of claim 12 , wherein the polysiloxane containing monomer is a polysiloxane containing cyclic monomer.

14. The ophthalmic lens of claim 12 , wherein the polysiloxane containing monomer is a polysiloxane containing polycyclic monomer.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Aug 28, 2009
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS, INC.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE
Reel/Frame 023163/0134 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2005
From: SCHORZMAN, DEREK; SALAMONE, JOSEPH C.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016726/0177 →